Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122779072 | 12277907 | 2 | F | 20160301 | 20160627 | 20160418 | 20160705 | EXP | JP-BAYER-2016-069305 | BAYER | 66.00 | YR | E | M | Y | 52.30000 | KG | 20160705 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122779072 | 12277907 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 800 MG | 21923 | 800 | MG | FILM-COATED TABLET | |||||||
| 122779072 | 12277907 | 2 | C | DOMPERIDONE | DOMPERIDONE | 1 | Oral | DAILY DOSE 30 MG | 0 | 30 | MG | ||||||||
| 122779072 | 12277907 | 3 | C | EXCELASE | PANCRELIPASE | 1 | Oral | UNK | 0 | ||||||||||
| 122779072 | 12277907 | 4 | C | FLAVITAN | FLAVIN ADENINE DINUCLEOTIDE | 1 | Oral | DAILY DOSE 15 MG | 0 | 15 | MG | TABLET | |||||||
| 122779072 | 12277907 | 5 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | DAILY DOSE 10 MG | 0 | 10 | MG | TABLET | |||||||
| 122779072 | 12277907 | 6 | C | NOVAMIN | PROCHLORPERAZINE MALEATE | 1 | Oral | DAILY DOSE 15 MG | 0 | 15 | MG | ||||||||
| 122779072 | 12277907 | 7 | C | OXINORM [OXYCODONE HYDROCHLORIDE] | 2 | Oral | DAILY DOSE 2.5 MG | 0 | 2.5 | MG | |||||||||
| 122779072 | 12277907 | 8 | C | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Transdermal | DAILY DOSE 1 MG | 0 | 1 | MG | ||||||||
| 122779072 | 12277907 | 9 | C | ANPEC [MORPHINE HYDROCHLORIDE] | 2 | Rectal | DAILY DOSE 10 MG | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122779072 | 12277907 | 1 | Hepatocellular carcinoma |
| 122779072 | 12277907 | 2 | Abdominal discomfort |
| 122779072 | 12277907 | 5 | Cancer pain |
| 122779072 | 12277907 | 6 | Vomiting |
| 122779072 | 12277907 | 7 | Cancer pain |
| 122779072 | 12277907 | 8 | Cancer pain |
| 122779072 | 12277907 | 9 | Cancer pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122779072 | 12277907 | DE |
| 122779072 | 12277907 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122779072 | 12277907 | Ascites | |
| 122779072 | 12277907 | Hepatocellular carcinoma | |
| 122779072 | 12277907 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122779072 | 12277907 | 1 | 20160217 | 201603 | 0 | |
| 122779072 | 12277907 | 2 | 20160104 | 20160318 | 0 | |
| 122779072 | 12277907 | 3 | 20160309 | 20160318 | 0 | |
| 122779072 | 12277907 | 4 | 20160310 | 20160318 | 0 | |
| 122779072 | 12277907 | 5 | 20160311 | 20160315 | 0 | |
| 122779072 | 12277907 | 6 | 20160313 | 20160318 | 0 | |
| 122779072 | 12277907 | 7 | 20160313 | 20160319 | 0 | |
| 122779072 | 12277907 | 8 | 20160315 | 20160319 | 0 | |
| 122779072 | 12277907 | 9 | 20160315 | 20160319 | 0 |